The best weight loss supplements that work for both men and women. These 2 weight loss supplements are safe, natural & healthy. ![]() My 4 day Weight Loss Program will show you how to Lose Weight Fast in 4 Days! The best weight loss plan for Fast Weight Loss. A new type of balloon-in-a-pill may offer a nonsurgical way for obese people to shed pounds -- and get healthier, too, a small study hints. The approach is straightforward: One or more balloons are placed in the stomach, then inflated - - allowing them to take up space and curb the patient's appetite. There are already a few weight- loss balloons on the market in the United States. Two, called Re. Shape and Orbera, are ingested with the help of an endoscope placed in the mouth and threaded down into the stomach. Another, called Obalon, is swallowed via a capsule. The capsule, which is tethered to a thin catheter, dissolves once it reaches the stomach, revealing the balloon. The balloon is then inflated with air through the catheter. All three balloon devices must be removed through an endoscope after six months. The device tested in the new study is different in a few ways, said researcher Dr. Hidetoshi Ohta, of Otaru Ekisaikai Hospital in Japan. Like Obalon, it is taken by pill. But, Ohta explained, there is no need for an endoscope. The balloon is deflated, then excreted the natural way six months after it's swallowed.
The new device also has a . The valve can be opened at any time to deflate the balloon - - in an emergency, for instance. The study - - which had no industry funding, Ohta said - - involved 1. All were treated with the gastric balloon, along with diet and exercise changes - - key components of all the approved balloon systems. After six months, the patients had lost almost 1. Beyond that, Ohta said, their insulin levels dipped by 2. Obese people commonly become resistant to insulin's effects, which is a precursor to type 2 diabetes. Ohta said the findings suggest the balloon therapy can not only spur weight loss, but might also help control type 2 diabetes and high cholesterol. But a weight- loss surgeon who was not involved in the study was skeptical. Dr. Mitchell Roslin is chief of obesity surgery at Lenox Hill Hospital in New York City. It's no surprise that patients in this study saw improvements in insulin and LDL levels, Roslin said. They work, but only for a while. And people often gain back all of the weight they lost, and then some, Roslin said. They include nausea, vomiting and stomach ulcers, according to the U. S. Food and Drug Administration. Also, earlier this year, the FDA warned doctors of two potential problems with the Re. Shape and Orbera balloons - - which are filled with fluid, rather than air. The devices, the agency said, can spontaneously overinflate, sometimes causing abdominal pain, breathing problems and vomiting. Some patients have also developed pancreatitis - - inflammation of the pancreas - - because of compression from the balloons. If either problem arises, patients may need the device removed, the FDA said. Ohta acknowledged that his study was very small and short- term. He said larger, longer- term trials are planned. Ohta presented his initial findings with the device on Monday at the annual Digestive Disease Week meeting of gastroenterologists, in Chicago. The results should be considered preliminary until they're published in a peer- reviewed medical journal. Copyright . All rights reserved. SOURCES: Hidetoshi Ohta, M. D., Otaru Ekisaikai Hospital, Otaru, Japan; Mitchell Roslin, M. D., chief, obesity surgery, Lenox Hill Hospital, New York City; May 8, 2. American Society for Gastrointestial Endoscopy meeting, Chicago.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
July 2017
Categories |